AzTrials
AzTrials

Emergency Service, HospitalNCT06535347

Nudging High-acuity Emergency Department Patients to Schedule a Follow-up Visit

A study testing Information about scheduling a follow-up appointment in people with Emergency Service, Hospital, run by Geisinger Clinic at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this campaign is to reduce unnecessary emergency department (ED) visits by encouraging patients with high acuity visits to follow up with an appropriate primary care provider (PCP) or specialist and therefore obtain appropriate care outside of the ED. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Emergency Service, Hospital
What is being tested?
Information about scheduling a follow-up appointment
Could I receive a placebo?
No, everyone receives an active treatment
How many people
6,814 participants
Where
1 siteUnited States
Study dates
9 Aug 2024to 6 Apr 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • >= 18 years of age
  • ED visit rated as high acuity (level L2 or L3)
  • Discharged from ED in past 24 hours
  • Attributed to a Geisinger PCP in Community Medicine Service Line

Who cannot join

  • Have an appointment scheduled within 7 days following discharge with a primary care provider or specialist
  • Institutionalized
  • Cannot be contacted via the communication modality being used in the study (i.e., SMS), due to insufficient/missing contact information in the electronic health record or because the patient opted out
  • Admitted to hospital
  • Eloped from ED
  • Left ED without being seen
  • Deceased prior to messaging

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Geisinger Health System

    Danville, Pennsylvania, 17822

Other trials in United States

About this study

Official title: Nudging High-acuity Emergency Department Patients to Schedule a Follow-up Visit With a Primary Care Provider or Specialist Following Discharge to Decrease Emergency Department Utilization

The goal of this campaign is to reduce unnecessary emergency department (ED) visits by encouraging patients with high acuity visits to follow up with an appropriate primary care provider (PCP) or specialist and therefore obtain appropriate care outside of the ED. In this campaign, patients will be assigned to receive or not receive outreach following ED discharge that is aligned with the goal. Outreach will occur via a text message and information added to the patient's after visit summary, and will include a contact number to schedule and hyperlink to allow self-scheduling. The study will assess whether ED use differs across patients in different outreach conditions. It will also examine whether patients followed through on the calls to action in the messages differently across conditions.

Read the detailed description

Enrollment will conclude when either 7500 participants have been enrolled or after 120 days, whichever occurs first.

Being tested
Information about scheduling a follow-up appointment
Medical subject headings
Emergencies

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Information about scheduling a follow-up appointmentBehavioural

    Also called Text messages, Information

    Text message(s) will be sent following discharge from the emergency department, along with an after visit summary.

Study groups in NCT06535347
Study groupRoleWhat they receive
ControlNo interventionThis arm will receive no intervention outside of usual care.
Experimental: Schedule Follow-Up Visit - 1 messageExperimentalThis arm will receive a text message (at 1 day post-ED discharge) and information added to the patient's after visit summary providing a number and patient portal hyperlink via which to schedule an ED follow-up appointment.
Receives: Behavioral: Information about scheduling a follow-up appointment
Experimental: Schedule Follow-Up Visit - 2 messagesExperimentalThis arm will receive text messages (at 1 day and 8 days post-ED discharge) and information added to the patient's after visit summary providing a number and patient portal hyperlink via which to schedule an ED follow-up appointment.
Receives: Behavioral: Information about scheduling a follow-up appointment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Return to ED

    ED visit (yes/no)

    Measured: within 120 days following day of discharge

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Aug 2024
  2. Study start9 Aug 2024
  3. Primary completion6 Apr 2025
  4. Study completion6 Apr 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
6,814 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06535347
Sponsor's protocol ID
2024-0412
Status last verified
Jun 2025
First submitted
8 Jul 2024
Last updated
5 Jun 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Information about scheduling a follow-up appointment in people with Emergency Service, Hospital, run by Geisinger Clinic at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Return to ED (time frame: within 120 days following day of discharge). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Jun 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in